OBJECTIVES: We assessed the association between depression and sudden cardiac death (SCD) and cardiac events among individuals without baseline coronary heart disease (CHD). BACKGROUND: Depression is a risk factor for cardiac events and mortality among those with CHD, possibly from arrhythmia. METHODS: We studied depressive symptoms and a proxy variable for clinical depression consisting of severe symptoms and/or antidepressant medication use and their relationship to cardiac events in the Nurses' Health Study. Questionnaires in 1992, 1996, and 2000 assessed symptoms with the Mental Health Index (MHI-5), and antidepressant use was assessed in 1996 and 2000. Primary end points included SCD, fatal CHD, and nonfatal myocardial infarction. RESULTS: Among 63,469 women without prior CHD/stroke in 1992, 7.9% had MHI-5 scores <53, previously found to predict clinical depression. Depressive symptoms were associated with CHD events, and the relationship was strongest for fatal CHD, where the association remained significant even after controlling for CHD risk factors (hazard ratio [HR]: 1.49; 95% confidence interval [CI]: 1.11 to 2.00 for MHI-5 score <53). In models from 1996 onward, our proxy variable for clinical depression was most associated with SCD in multivariable models (HR: 2.33, 95% CI: 1.47 to 3.70), and this risk was primarily due to a specific relationship between antidepressant use and SCD (HR: 3.34, 95% CI: 2.03 to 5.50). CONCLUSIONS: In this cohort of women without baseline CHD, depressive symptoms were associated with fatal CHD, and a measure of clinical depression including antidepressant use was specifically associated with SCD. Although antidepressant use might be a marker of worse depression, its specific association with SCD merits further study.
OBJECTIVES: We assessed the association between depression and sudden cardiac death (SCD) and cardiac events among individuals without baseline coronary heart disease (CHD). BACKGROUND: Depression is a risk factor for cardiac events and mortality among those with CHD, possibly from arrhythmia. METHODS: We studied depressive symptoms and a proxy variable for clinical depression consisting of severe symptoms and/or antidepressant medication use and their relationship to cardiac events in the Nurses' Health Study. Questionnaires in 1992, 1996, and 2000 assessed symptoms with the Mental Health Index (MHI-5), and antidepressant use was assessed in 1996 and 2000. Primary end points included SCD, fatal CHD, and nonfatal myocardial infarction. RESULTS: Among 63,469 women without prior CHD/stroke in 1992, 7.9% had MHI-5 scores <53, previously found to predict clinical depression. Depressive symptoms were associated with CHD events, and the relationship was strongest for fatal CHD, where the association remained significant even after controlling for CHD risk factors (hazard ratio [HR]: 1.49; 95% confidence interval [CI]: 1.11 to 2.00 for MHI-5 score <53). In models from 1996 onward, our proxy variable for clinical depression was most associated with SCD in multivariable models (HR: 2.33, 95% CI: 1.47 to 3.70), and this risk was primarily due to a specific relationship between antidepressant use and SCD (HR: 3.34, 95% CI: 2.03 to 5.50). CONCLUSIONS: In this cohort of women without baseline CHD, depressive symptoms were associated with fatal CHD, and a measure of clinical depression including antidepressant use was specifically associated with SCD. Although antidepressant use might be a marker of worse depression, its specific association with SCD merits further study.
Authors: Candyce H Kroenke; Gary G Bennett; Charles Fuchs; Ed Giovannucci; Ichiro Kawachi; Eva Schernhammer; Michelle D Holmes; Laura D Kubzansky Journal: Am J Epidemiol Date: 2005-10-05 Impact factor: 4.897
Authors: Glen L Xiong; Wei Jiang; Robert Clare; Linda K Shaw; Peter K Smith; Kenneth W Mahaffey; Christopher M O'Connor; K Ranga R Krishnan; L Kristin Newby Journal: Am J Cardiol Date: 2006-05-05 Impact factor: 2.778
Authors: William Whang; Christine M Albert; Samuel F Sears; Rachel Lampert; Jamie B Conti; Paul J Wang; Jagmeet P Singh; Jeremy N Ruskin; James E Muller; Murray A Mittleman Journal: J Am Coll Cardiol Date: 2005-04-05 Impact factor: 24.094
Authors: Andrew Sherwood; James A Blumenthal; Ranak Trivedi; Kristy S Johnson; Christopher M O'Connor; Kirkwood F Adams; Carla Sueta Dupree; Robert A Waugh; Daniel R Bensimhon; Laura Gaulden; Robert H Christenson; Gary G Koch; Alan L Hinderliter Journal: Arch Intern Med Date: 2007-02-26
Authors: Alexander H Glassman; Christopher M O'Connor; Robert M Califf; Karl Swedberg; Peter Schwartz; J Thomas Bigger; K Ranga Rama Krishnan; Louis T van Zyl; J Robert Swenson; Mitchell S Finkel; Charles Landau; Peter A Shapiro; Carl J Pepine; Jack Mardekian; Wilma M Harrison; David Barton; Michael Mclvor Journal: JAMA Date: 2002-08-14 Impact factor: 56.272
Authors: Viola Vaccarino; B Delia Johnson; David S Sheps; Steven E Reis; Sheryl F Kelsey; Vera Bittner; Thomas Rutledge; Leslee J Shaw; George Sopko; C Noel Bairey Merz Journal: J Am Coll Cardiol Date: 2007-11-05 Impact factor: 24.094
Authors: Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal Journal: N Engl J Med Date: 2008-01-17 Impact factor: 91.245
Authors: An Pan; Olivia I Okereke; Qi Sun; Giancarlo Logroscino; JoAnn E Manson; Walter C Willett; Alberto Ascherio; Frank B Hu; Kathryn M Rexrode Journal: Stroke Date: 2011-08-11 Impact factor: 7.914
Authors: An Pan; Michel Lucas; Qi Sun; Rob M van Dam; Oscar H Franco; JoAnn E Manson; Walter C Willett; Alberto Ascherio; Frank B Hu Journal: Arch Intern Med Date: 2010-11-22
Authors: Benjamin D Capistrant; Paola Gilsanz; J Robin Moon; Anna Kosheleva; Kristen K Patton; M Maria Glymour Journal: Ethn Dis Date: 2013 Impact factor: 1.847